PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.71
ESG score 60-70 - Adequate ESG practices that Peter Lynch might accept. Verify if governance quality supports management accountability and shareholder interests.
54.44
Environmental score 60-70 - Adequate environmental stewardship that Peter Lynch might accept. Verify if climate risk management protects long-term cash flows.
58.35
Social score 60-70 - Adequate social responsibility that Peter Lynch might accept. Verify if stakeholder management supports long-term brand value and pricing power.
57.34
Governance score 60-70 - Adequate governance that Peter Lynch might accept. Verify if board oversight ensures management acts in shareholder interests.